Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

’Disappearing’ tumour study could lead to new cancer treatments

04.06.2003


A research study at The University of Nottingham looking at how growth can contribute to spontaneous childhood cancer regression could lead to more effective ways of treating tumours.



The one-year project, led by Christopher Jones in the School of Nursing in collaboration with Dr Michael Symonds in the Division of Child Health and Dr David Walker at the University’s Children’s Brain Tumour Research Centre, will look at whether growth hormone plays a part in tumours spontaneously getting better.

The researchers are looking at neuroblastoma, which accounts for around six per cent of all childhood cancers. Around 100 children develop neuroblastoma each year in the UK and most of these are less than four years of age.


In around three-quarters of these cases the cancer spreads around the body and the current survival rates are only around 30 per cent.

However, when a tumour of this kind occurs in the liver, particularly in the first year of life, it is only fatal in between 10 and 20 per cent of sufferers and, in many cases, spontaneously regresses without the need for treatment.

Scientists have been studying this medical phenomenon for many years, although most research has centred on looking at the biology of the tumour in an effort to discover why it self-destructs.

The Nottingham researchers, however, believe it could be something within the body and not the tumour itself that sparks off this regression and think that it could be due to the release of hormones that control growth in infancy.

Dr Michael Symonds said: "We believe that spontaneous tumour regression is linked to unique changes within the liver in early childhood, which coincide with the onset of growth hormone-dependent growth."

It is hoped that the study, funded with £7,000 from the Special Trustees of Nottingham University Hospital, will attract more funding for the study of childhood cancers and could even lead to more effective treatments for non-regressing neuroblastoma, as well as other aggressive tumours such as breast cancer and certain types of childhood brain tumours.

Lyn Heath-Harvey | alfa
Further information:
http://www.nottingham.ac.uk/public-affairs/index.html

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

Method uses DNA, nanoparticles and lithography to make optically active structures

19.01.2018 | Materials Sciences

More genes are active in high-performance maize

19.01.2018 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>